These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1286527)

  • 1. Non-autonomy of parathyroid hormone secretion in acute primary hyperparathyroidism.
    Schachter PP; Christy MD; Avigad IS; Shabtay M; Leight GS
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):565-9. PubMed ID: 1286527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.
    Cetani F; Picone A; Cerrai P; Vignali E; Borsari S; Pardi E; Viacava P; Naccarato AG; Miccoli P; Kifor O; Brown EM; Pinchera A; Marcocci C
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4789-94. PubMed ID: 11134144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered parathyroid set point to calcium in familial hypocalciuric hypercalcaemia.
    Auwerx J; Demedts M; Bouillon R
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):215-8. PubMed ID: 6428123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cimetidine on circulating parathyroid hormone in primary hyperparathyroidism.
    Sherwood JK; Ackroyd FW; Garcia M
    Lancet; 1980 Mar; 1(8169):616-20. PubMed ID: 6102626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism.
    Indridason OS; Heath H; Khosla S; Yohay DA; Quarles LD
    Kidney Int; 1996 Nov; 50(5):1663-71. PubMed ID: 8914034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretion of intact PTH by dispersed human hyperparathyroid cells.
    Aston JP; Brown RC; Curley I; Wheeler MH; Woodhead JS
    Clin Endocrinol (Oxf); 1988 Dec; 29(6):643-8. PubMed ID: 3256447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic PTH syndrome, pseudohyperparathyroidism; hypercalcaemia of malignancy.
    Buckle R
    Clin Endocrinol Metab; 1974 Jul; 3(2):237-51. PubMed ID: 4611664
    [No Abstract]   [Full Text] [Related]  

  • 9. Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism.
    Weber CJ; Russell J; Chryssochoos JT; Hagler M; McGarity WC
    World J Surg; 1996 Oct; 20(8):1010-4; discussion 1014-5. PubMed ID: 8798358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between external and cytoplasmic calcium concentrations, parathyroid hormone release and weight of parathyroid glands in human hyperparathyroidism.
    Wallfelt C; Gylfe E; Larsson R; Ljunghall S; Rastad J; Akerström G
    J Endocrinol; 1988 Mar; 116(3):457-64. PubMed ID: 3351432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological regulation of parathyroid hormone secretion.
    Nemeth EF
    Curr Pharm Des; 2002; 8(23):2077-87. PubMed ID: 12171519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperphosphatemia modestly retards parathyroid hormone suppression during calcitriol-induced hypercalcemia in normal and azotemic rats.
    Jara A; Chacón C; Felsenfeld AJ
    Nephron; 2002 Dec; 92(4):883-8. PubMed ID: 12399635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intact parathyroid hormone in primary hyperparathyroidism.
    Flentje D; Schmidt-Gayk H; Fischer S; Stern J; Blind E; Buhr H; Herfarth C
    Br J Surg; 1990 Feb; 77(2):168-72. PubMed ID: 2317677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTHrP enhances the secretory response of PTH to a hypocalcemic stimulus in rat parathyroid glands.
    Lewin E; Almaden Y; Rodriguez M; Olgaard K
    Kidney Int; 2000 Jul; 58(1):71-81. PubMed ID: 10886551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo studies of parathyroid gland function in secondary hyperparathyroidism.
    Salusky IB; Goodman WG
    Adv Nephrol Necker Hosp; 1996; 25():289-302. PubMed ID: 8717632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Hyperparathyroidism With Undetectable Intact Parathyroid Hormone.
    Song Z; McMullin J; Huls F; Rosenthal R; Bantu S; Wu C; Chen H; Lindeman B
    Clin Med Insights Endocrinol Diabetes; 2024; 17():11795514241290125. PubMed ID: 39381434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory dysfunction in parathyroid cells from a neonate with severe primary hyperparathyroidism.
    Marx SJ; Lasker RD; Brown EM; Fitzpatrick LA; Sweezey NB; Goldbloom RB; Gillis DA; Cole DE
    J Clin Endocrinol Metab; 1986 Feb; 62(2):445-9. PubMed ID: 3941166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic value of parathyroid hormone washout after fine-needle aspiration of suspicious cervical lesions in patients with hyperparathyroidism.
    Abdelghani R; Noureldine S; Abbas A; Moroz K; Kandil E
    Laryngoscope; 2013 May; 123(5):1310-3. PubMed ID: 23553068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo assessments of calcium-regulated parathyroid hormone release in secondary hyperparathyroidism.
    Goodman WG; Belin TR; Salusky IB
    Kidney Int; 1996 Dec; 50(6):1834-44. PubMed ID: 8943464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prevalence of primary hyperparathyroidism in treated breast cancer.
    Fierabracci P; Pinchera A; Miccoli P; Conte PF; Vignali E; Zaccagnini M; Marcocci C; Giani C
    J Endocrinol Invest; 2001 May; 24(5):315-20. PubMed ID: 11407650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.